Title
Personalized Automatic Management of Tracheal Cuff Pressure and Subglottic Secretion Drainage to Prevent Pneumonia in Critically Ill Intubated Patients: The MICROINHALO Multicenter Randomized Controlled Trial
Summary
The MICROINHALO trial tested whether automatic, personalized control of endotracheal cuff pressure plus subglottic secretion drainage could reduce airway colonization and ventilator-associated pneumonia in critically ill intubated patients. It did not reduce colonization, but it was associated with fewer pneumonia cases and better cuff pressure control.
Background
Patients in intensive care units who require endotracheal intubation and mechanical ventilation are at risk of ventilator-associated pneumonia, or VAP. This serious infection develops when bacteria from the mouth, throat, or stomach leak around the breathing tube and reach the lower airways. Two common preventive strategies are keeping the cuff pressure of the tube in a safe range and draining secretions that collect above the cuff, known as subglottic secretions.
If cuff pressure is too low, secretions can leak past the cuff into the lungs. If it is too high, it can injure the tracheal wall. In routine practice, cuff pressure is often checked manually at intervals, but pressure can fluctuate between measurements. The MICROINHALO trial examined whether a system that automatically adjusts cuff pressure based on exhaled carbon dioxide measurements, together with automatic drainage of secretions, could improve outcomes compared with standard manual care.
Study Design
MICROINHALO was a cluster-randomized, international, open-label trial registered as NCT05403320. It enrolled adult patients in 10 intensive care units. A total of 270 patients were randomized, and 250 were included in the final analysis.
Patients were assigned to one of two approaches:
1. Automatic management group: endotracheal tube equipped with automatic cuff pressure management guided by exhaled CO2 monitoring and automatic subglottic secretion drainage.
2. Control group: conventional tube management with manual cuff pressure checks and manual subglottic secretion drainage.
The main outcome was bacterial tracheal colonization on day 3 after intubation, defined as more than 10^3 colony-forming units per milliliter. Tracheal colonization means that bacteria are present in airway secretions; while this is not the same as pneumonia, it may reflect a higher risk of later infection.
Main Findings
On day 3 after intubation, bacterial tracheal colonization occurred in 47 patients, or 37%, in the automatic management group, compared with 51 patients, or 41.5%, in the manual management group. This difference was not statistically significant. In other words, automatic management did not outperform manual care for the primary endpoint of preventing early airway colonization.
However, several secondary outcomes favored the automatic management approach. Clinically diagnosed ventilator-associated pneumonia occurred in 12.6% of patients in the automatic group versus 24.4% in the control group. Microbiologically confirmed VAP occurred in 10.2% versus 19.5%, respectively. Both reductions were statistically significant.
The automatic group also had fewer cuff pressure measurements outside the target safety range, suggesting more stable and reliable cuff control. In addition, daily subglottic secretion drainage volumes were higher in the automatic group, indicating more effective removal of secretions that could otherwise pool above the cuff and potentially be aspirated into the lungs.
What the Results Mean
The trial’s primary question was whether better control of the airway environment would reduce bacterial colonization early after intubation. The answer was no, at least not to a statistically significant degree. This suggests that colonization may be influenced by multiple factors beyond cuff pressure and secretion drainage alone, including the patient’s underlying illness, oral hygiene, antibiotic exposure, duration of ventilation, and contamination from the upper airway.
At the same time, the lower rates of clinically diagnosed and microbiologically confirmed VAP in the automatic group are important. VAP is one of the most serious complications of mechanical ventilation because it can prolong ICU stay, increase antibiotic use, and worsen outcomes. The findings raise the possibility that automatic cuff regulation and more effective drainage may meaningfully reduce pneumonia even if they do not clearly prevent early colonization.
It is important to interpret the secondary findings cautiously. Because the trial was powered primarily for colonization rather than pneumonia, the VAP results should be considered promising but not definitive. Further larger studies will be needed to confirm whether these benefits are real and reproducible across different ICU settings.
Why Cuff Pressure Matters
Endotracheal tube cuffs are designed to seal the airway so that mechanical ventilation works properly and secretions do not leak into the lungs. In practice, cuff pressure can vary because of changes in patient position, coughing, ventilator settings, tube movement, and gas diffusion over time. Manual checks may miss these fluctuations.
Automatic monitoring aims to keep pressure continuously within a safe zone. This may reduce microaspiration, which is the small but repeated leakage of contaminated secretions around the cuff. Over time, even small leaks can contribute to infection. The MICROINHALO study supports the idea that maintaining more stable cuff pressure is feasible and may help lower pneumonia risk.
Role of Subglottic Secretion Drainage
Subglottic secretion drainage is a preventive technique in which secretions that accumulate above the cuff are removed through a special tube channel. These secretions can contain bacteria and inflammatory material. If they are not drained, they can slip past the cuff and enter the lower respiratory tract.
In MICROINHALO, the automatic group had a higher daily drainage volume, which may reflect more consistent removal of secretions. This could partly explain the lower VAP rates observed. The study reinforces the clinical value of subglottic secretion management as part of an overall ventilator-associated pneumonia prevention strategy.
Clinical Implications
For intensive care teams, the trial suggests several practical points:
1. Automated cuff pressure systems can improve pressure stability.
2. Better secretion drainage may reduce the risk of pneumonia.
3. Tracheal colonization alone may not be the best surrogate marker for VAP prevention.
4. Technology may offer an advantage, but it should complement, not replace, established infection-prevention bundles.
Standard ICU measures remain essential, including head-of-bed elevation, oral hygiene, sedation minimization when possible, early mobilization, appropriate suctioning, and careful ventilator management. Automatic cuff pressure systems may be most useful when integrated into a broader prevention protocol.
Limitations
Like all clinical trials, MICROINHALO has limitations. It was open-label, so clinicians knew which device each patient received. That can sometimes influence diagnosis or care practices. The study also focused on a specific ICU population and device strategy, so results may not apply equally to all hospitals or all endotracheal tube designs.
Another important point is that the primary endpoint was bacterial tracheal colonization, not VAP itself. Because the trial was not primarily designed to prove a pneumonia reduction, the favorable VAP findings should be seen as hypothesis-generating. More research is needed to determine which patients benefit most, how large the effect is, and whether the approach improves harder outcomes such as length of ventilation, ICU stay, or mortality.
Conclusion
The MICROINHALO multicenter randomized trial found that personalized automatic management of tracheal cuff pressure combined with subglottic secretion drainage did not significantly reduce early bacterial tracheal colonization in critically ill intubated patients. However, it was associated with fewer ventilator-associated pneumonia cases and better cuff pressure control.
These results suggest that automated airway management may have a meaningful role in preventing pneumonia in the ICU, but confirmation from additional large-scale studies is needed before it can be considered a proven superior standard of care.